Global Antibiotics Market By Action Overview
Antibiotic is an antimicrobial substance, which combats bacterial infections and occasionally protozoan infections. Also, they are used to cure several diseases such as strep throat, urinary tract infections, sinus infections, pneumonia, skin infections, ear infections, and others. Antibiotics are also known as antibacterial or antimicrobials. Since the discovery of the antibiotic penicillin in 1920, various antibiotic compounds have been used to treat several bacterial infections. Increase in the incidence of chronic and infectious diseases across the globe and the efficacy of antibiotics to treat a wide spectrum of bacterial infections have led to the rapid growth of the antibiotics market.
Global Antibiotics Market By Action Dynamics
Rising prevalence of infectious diseases
Rising prevalence of infectious diseases, such as HIV/AIDS, pneumonia, malaria, and tuberculosis, and the current gap in the demand and supply of antibiotics are the other factors propelling the market. Government reforms specific to antibiotics, such as the Generating Antibiotics Incentives Now (GAIN) Act in U.S., are projected to help boost the market growth over the forecast period. However, the indiscriminate and sustained use of antibiotics in the last few decades has led to the development of antibiotic-resistant bacteria and pathogens. Infections such as tuberculosis, pneumonia, and gonorrhoea, which were initially susceptible to antibiotics, have become immune to these drugs.
Global Antibiotics Market By Action Segmentation
Antibiotics market is segmented based on the action mechanism, drug, and region.
Based on the action mechanism, the antibiotics market is segmented into cell wall synthesis inhibitors, protein synthesis inhibitors, DNA synthesis inhibitors, RNA synthesis inhibitors, and mycolic acid inhibitors. . Folic acid and RNA synthesis inhibitors are anticipated to witness significant CAGRs over the forecast period. Developments of several antiviral drugs, which inhibit transcription and reverse transcription process, are anticipated to support the growth. Folic acid inhibitor sulfa drugs are anticipated to grow as they have a wide scope of application. Based on the drug, the global market is segmented into cephalosporin, penicillin, fluoroquinolone, macrolides, carbapenem, aminoglycosides, and sulfonamides, and others. Increasing incidence of pneumonia, bloodstream infections, and Urinary Tract Infections (UTI) is anticipated to foster the usage of carbapenems class of antibiotics.
Regional Insights:
Based on the region the Craft Spirit market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America held a substantial share of the global market in 2018. Healthcare system in the North American region facilitates the usage of branded products, however with the loss of exclusivity of certain molecules, sales in this region eroded significantly in the past few years. The Asia Pacific held a significant share in the past on account of the large population base, high prevalence of infectious diseases, regulation reforms, and greater usage of generic medicines. Latin America, especially Brazil, with its strong growth in the pharmaceuticals sector is also projected to exhibit remunerative growth. The outbreak of certain viruses, such as Ebola, in Africa contributed to the growth of the region.
Antibiotics Market, By Action Mechanism:
- Cell Wall Synthesis Inhibitors
- Protein Synthesis Inhibitors
- DNA Synthesis Inhibitors
- RNA Synthesis Inhibitors
- Mycolic Acid Inhibitors
Antibiotics Market, By Drug:
- Cephalosporin
- Penicillin
- Fluoroquinolone
- Macrolides
- Carbapenem
- Aminoglycosides
- Sulfonamides
- Others
Antibiotics Market, By Region:
- North America
- North America Antibiotics Market, By Action Mechanism
- North America Antibiotics Market, By Drug
- North America Antibiotics Market, By Region
- Middle East & Africa
- Middle East & Africa Antibiotics Market, By Action Mechanism
- Middle East & Africa Antibiotics Market, By Drug
- Middle East & Africa Antibiotics Market, By Region
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Latin America Antibiotics Market, By Action Mechanism
- Latin America Antibiotics Market, By Drug
- Latin America Antibiotics Market, By Region
- Brazil
- Mexico
- Rest of Latin America
- Asia Pacific
- Asia Pacific Antibiotics Market, By Action Mechanism
- Asia Pacific Antibiotics Market, By Drug
- Asia Pacific Antibiotics Market, By Region
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
- Europe
- Europe Antibiotics Market, By Action Mechanism
- Europe Antibiotics Market, By Drug
- Europe Antibiotics Market, By Region
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
-
- U.S.
- Canada
- Middle East & Africa
Global Antibiotics Market By Action Key Players
The key players operating the antibiotics market involves Pfizer, Inc.; Janssen Pharmaceuticals; Abbott Laboratories; GlaxoSmithKline plc; Sanofi S.A.; Novartis AG; Bayer AG; Bristol Myers Squibb Company; Eli Lilly and Company; and Astellas Pharma, Inc. Prominent players operating in the target market are focusing on strategic partnerships as well as the launching of the products to gain a competitive edge in the target market. For instance, in February 2020, Seattle Genetics and Astellas Announce Updated Result from Phase 1b/2 Trial of PADCEV™ (enfortumab vedotin-ejfv) in Combination with Immune Therapy Pembrolizumab as Investigational First-Line Treatment for Advanced Bladder Cancer. In January 2020, Janssen Announces European Commission Approval for Expanded Use of Erleada (apalutamide) for Treatment of Patients with Metastatic Hormone-Sensitive Prostate Cancer.
Global Antibiotics Market By Action Company Profile
- Pfizer, Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business strategies
- Janssen Pharmaceuticals
- Abbott Laboratories
- GlaxoSmithKline plc
- Sanofi S.A.
- Novartis AG
- Bayer AG
- Bristol Myers Squibb Company
- Eli Lilly and Company
- Astellas Pharma, Inc.
“*” marked represents similar segmentation in other categories in the respective section
Global Antibiotics Market By Action Table of Contents
- Research Objective and Assumption
- Preface
- Research Objectives
- Study Scope
- Years Considered for the study
- Assumptions
- Abbreviations
- Research Methodology
- Research data
- Primary Data
- Primary Interviews
- Primary Breakdown
- Key data from Primary Sources
- Key Industry Insights
- Secondary Data
- Major Secondary Sources
- Secondary Sources
- Market Estimation
- Top-Down Approach
- Approach for estimating Market Share by Top-Down Analysis (Supply Side)
- Bottom-Up Approach
- Approach for estimating market share by Bottom-up Analysis (Demand Side)
- Market Breakdown and Data Triangulation
- Research Assumptions
- Market Purview
- Executive Summary
- Key Findings—Global Outlook for Antibiotics Strategies
- Key Questions this Study will Answer
- Market Snippet, By Action Mechanism
- Market Snippet, By Drug
- Market Snippet, By Region
- Opportunity Map Analysis
- Executive Summary—3 Big Predictions
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Market Trends
- DR Impact Analysis
- PEST Analysis
- Porter’s Five Forces Analysis
- Opportunity Orbit
- Market Investment Feasibility Index
- Macroeconomic Factor Analysis
- Market Dynamics
- Market Segmentation, By Action Mechanism, 2020 – 2030, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
- Y-o-Y Growth Analysis (%), 2020 – 2030
- Segment Trends
- Cell Wall Synthesis Inhibitors
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Protein Synthesis Inhibitors
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- DNA Synthesis Inhibitors
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- RNA Synthesis Inhibitors
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Mycolic Acid Inhibitors
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Overview
- Market Segmentation, By Drug, 2020 – 2030, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
- Y-o-Y Growth Analysis (%), 2020 – 2030
- Segment Trends
- Cephalosporin
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Penicillin
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Fluoroquinolone
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Macrolides
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Carbapenem
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Aminoglycosides
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Sulfonamides
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Other
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Overview
- Global Market, By Region, 2020 – 2030, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
- Y-o-Y Growth Analysis (%), 2020 – 2030
- Regional Trends
- North America
- Market Size and Forecast (US$ Mn), By Action Mechanism, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Drug, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Region, 2020 – 2030
- U.S.
- Canada
- Europe
- Market Size and Forecast (US$ Mn), By Action Mechanism, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Drug, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Region, 2020 – 2030
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia Pacific
- Market Size and Forecast (US$ Mn), By Action Mechanism, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Drug, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Region, 2020 – 2030
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
- Latin America
- Market Size and Forecast (US$ Mn), By Action Mechanism, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Drug, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Region, 2020 – 2030
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- Market Size and Forecast (US$ Mn), By Action Mechanism, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Drug, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Region, 2020 – 2030
- GCC
- Israel
- South Africa
- Rest of Middle East
- Overview
- Competitive Landscape
- Heat Map Analysis
- Market Presence and Specificity Analysis
- Company Profiles
- Pfizer, Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business strategies
- Pfizer, Inc.
- Janssen Pharmaceuticals
- Abbott Laboratories
- GlaxoSmithKline plc
- Sanofi S.A.
- Novartis AG
- Bayer AG
- Bristol Myers Squibb Company
- Eli Lilly and Company
- Astellas Pharma, Inc.
The Last Word
- Future Impact
- About Us
- Contact
FAQs
Antibiotics Market xx was valued at US$ Xx Billion in 2024 and is projected to grow at a CAGR of xx% to reach US$ xx Billion by 2034
Antibiotics Market is projected to increase at a CAGR of xx% during the forecast period
Antibiotics market is segmented based on the action mechanism, drug, and region.
Rising prevalence of infectious diseases, such as HIV/AIDS, pneumonia, malaria, and tuberculosis, and the current gap in the demand and supply of antibiotics are the other factors propelling the market.
Asia-Pacific is expected to remain dominant throughout the forecast period attributable to increased antibiotics consumption, their easy availability, and rise in sale of over-the-counter drugs.
Prominent players operating in the target market are focusing on strategic partnerships as well as the launching of the products to gain a competitive edge in the target market.